With Patients. For Patients: Our Unwavering Focus on Patient Centricity
Every year, Patient Engagement Leads across Pfizer collaborate with hundreds of Patient Advocacy Groups around the world to advance shared goals and better support the needs of patients everywhere. Pfizer’s Global Patient Advocacy team contributes to Pfizer’s end-to-end advocacy strategy by supporting teams to drive deep therapeutic and regional relationship models with patient advocacy groups. These partnerships can help improve patient outcomes by increasing patient engagement in research and development, elevating priority policy and social impact issues, creating meaningful resources and programs that provide value to patients and more.
From left to right: Carlos Murillo, Spain Country President, Pfizer, Mario Torbado, Regional Lead, Global Patient Advocacy, Europe, Pfizer, Daniel Gallego, President, European Kidney Patients Federation, Ana Castellanos, Coordinator and Project Manager, Plataforma de Organizaciones de Pacientes, Roberto Saldaña, Director of Innovation, EUPATI Spain
PatientView Corporate Reputation in Pharma Survey
In 2021, Pfizer was recognized as the most patient-centric organization among the world’s largest pharmaceutical companies, according to the PatientView Corporate Reputation of Pharma Survey. The survey, reaching more than 2,150 patient advocacy groups across 90 countries, measures their perceptions of pharma companies across nine indicators, including transparency, patient safety, quality information, integrity, support for patients and more. Pfizer colleagues use the feedback shared by advocates to further enhance our strategy for sustaining respectful, equitable, impactful, and culturally appropriate relationships with advocacy groups that help improve patient outcomes.
Patients in Focus Week
In October, we hosted our second annual Patients in Focus week, themed “With Patients. For Patients.” The week is a dedicated time for global Pfizer colleagues to reflect on the impact patients and advocates have on our work. Colleagues heard directly from patients and advocates in their local communities and met with Patient Engagement Leads who showcased best-in-class examples of patient advocacy and engagement.
Pfizer leaders kicked off the week by sharing our definition of patient centricity, co-created with colleagues, patients, and advocates.
Patient centricity exists at Pfizer when we listen and learn from the patient perspective, acting as partners with accountability and integrity to deliver outcomes that matter most to patients and those involved in their care.
Pfizer Hong Kong colleagues visit Rare Disease Hong Kong, a local patient group supporting cross-rare disease patients and their families, during Patients in Focus.
From left to right: Krishnamoorthy Sundaresan, Pfizer Hong Kong Country Manager; Kin Ping Tsang, Chairman, Rare Disease Hong Kong and President, Retina Hong Kong and guide dog Vinny; Kelly Fung, Patient Experience Partner, Pfizer Hong Kong
During the kickoff, Dr. Albert Bourla, Pfizer Chairman & Chief Executive Officer and Aida Habtezion, Pfizer Chief Medical Officer, answered questions from advocacy groups about how we are involving patients from the earliest stage of research and drug development to the final approval of our medicines and vaccines.
Pfizer Global Supply colleagues in Vizag, India celebrate Patients in Focus Week
Pictured from left to right: Sreenivas, Procurement Lead; Rajesh, Finance Lead; Rachna, CQ Lead; Satjeet, Digital Lead; Vikram, Site Head; Amar, Warehouse Lead; Rajesh, Automation and Instrumentation Lead; Vrushal, RA Lead; Vamsi, Quality Compliance Lead
Throughout the week more than 40,000 colleagues, from across 30 countries, attended patient panels and advocacy lunch-and-learns, blood drives and community volunteering initiatives, and health equity workshops, to name a few. Some Pfizer sites painted murals to display at nearby rehabilitation centers; others matched donations for local patient groups. No matter the event, colleagues reported a greater sense of connectedness, pride in their work, and a deeper understanding of the importance of patient advocacy and engagement.
